Berita English News

Sanofi Says Next-gen Covid Booster Shot Has Potential Against Main Variants

Senin, 13 Juni 2022 | 15:49 WIB
Sanofi Says Next-gen Covid Booster Shot Has Potential Against Main Variants

ILUSTRASI. Sanofi said an upgraded version of the Covid-19 vaccine candidate showed potential to protect against the virus's main variants. REUTERS/Dado Ruvic/Illustration/File Photo

Sumber: Reuters | Editor: Anastasia Lilin Yuliantina

KONTAN.CO.ID - PARIS. French drugmaker Sanofi said on Monday an upgraded version of the Covid-19 vaccine candidate it is developing with GSK showed potential in two trials to protect against the virus's main variants of concern, including the Omicron BA.1 and BA.2 strains, when used as a booster shot.

While the two companies' first experimental Covid shot is undergoing review by the European Medicines Agency, Sanofi and GSK have continued work on a vaccine that is molded on the now-supplanted Beta variant, hoping still that it will confer broad protection against future viral mutations.

Ini Artikel Spesial

Agar bisa lanjut membaca sampai tuntas artikel ini, pastikan Anda sudah berlangganan atau membeli artikel ini.

Sudah berlangganan? Masuk

Berlangganan

Berlangganan Hanya dengan 20rb/bulan Anda bisa mendapatkan berita serta analisis ekonomi, bisnis, dan investasi pilihan

Rp 20.000

Bayar per artikel

Hanya Rp 5.000 untuk membaca artikel ini

Rp 5.000

Berlangganan dengan Google

Anda dapat menggunakan akun Google sebagai metode pembayaran karena Google akan mengingat metode yang sudah pernah digunakan.

Terbaru